Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/8/2025

Mechanism of Action of Phenobarbital in Alcohol Withdrawal

Primary Mechanisms

  • Phenobarbital works in alcohol withdrawal through the same fundamental mechanism as alcohol itself—enhancing GABAergic inhibition in the central nervous system—while additionally blocking glutamate-mediated excitation, providing dual-mechanism control of the hyperexcitable state that characterizes withdrawal 1, 2
  • Phenobarbital acts primarily on GABA receptors in the CNS, producing sedation, anxiolysis, and anticonvulsant effects by enhancing inhibitory neurotransmission 3
  • The long half-life (80-120 hours) provides sustained GABA receptor activation, preventing the fluctuations in CNS depression that can occur with shorter-acting agents 2, 4

Clinical Implications of the Mechanism

  • Barbiturates exhibit cross-tolerance with alcohol and other CNS depressants because they act on overlapping receptor systems 1, 2
  • When combined with alcohol or other CNS depressants, additive depressant effects on the CNS and respiratory system occur, making overdose more dangerous 1, 2, 5
  • Tolerance to sedative-hypnotic effects develops with chronic use, but tolerance to lethal serum concentrations (causing respiratory failure) does not develop proportionally 1, 2, 4

Pharmacokinetic Properties Supporting Its Use

  • Phenobarbital has a volume of distribution of 0.25-1.2 L/kg and protein binding of only 20-60%, allowing effective CNS penetration 2, 4, 6
  • The elimination half-life of 80-120 hours and duration of action of 6-12 hours provides sustained coverage without frequent redosing 2, 4, 6
  • Approximately 20-25% is excreted unchanged in urine as a weak acid (pKa 7.2), with the remainder undergoing hepatic metabolism 2, 4

Metabolism and Drug Interactions

  • Hepatic metabolism via the cytochrome P450 system is the main route of clearance 1, 2, 7
  • Phenobarbital is a known inducer of the hepatic CYP450 enzyme system, increasing metabolic clearance of other CYP substrates 1, 2

Critical Safety Considerations

  • Barbiturates suppress the medullary respiratory center, causing dose-dependent respiratory depression 1, 6, 7
  • Cardiovascular depression occurs through medullary vasomotor center suppression, potentially causing hypotension 1, 6, 7